000			02251 a2200601 4500
005			20250515205406.0
264		0	_c20100407
008			201004s 0 0 eng d
022			_a1538-7445
024	7		_a10.1158/0008-5472.CAN-09-3367 _2doi
040			_aNLM _beng _cNLM
100	1		_aZander, Serge A L
245	0	0	_aSensitivity and acquired resistance of BRCA1;p53-deficient mouse mammary tumors to the topoisomerase I inhibitor topotecan. _h[electronic resource]
260			_bCancer research _cFeb 2010
300			_a1700-10 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aATP Binding Cassette Transporter, Subfamily B
650	0	4	_aATP Binding Cassette Transporter, Subfamily B, Member 1
650	0	4	_aATP Binding Cassette Transporter, Subfamily G, Member 2
650	0	4	_aATP-Binding Cassette Transporters _xgenetics
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xadministration & dosage
650	0	4	_aCarcinoma _xdrug therapy
650	0	4	_aDoxorubicin _xtherapeutic use
650	0	4	_aDrug Evaluation, Preclinical
650	0	4	_aDrug Resistance, Neoplasm _xgenetics
650	0	4	_aEnzyme Inhibitors _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aGene Expression Regulation, Neoplastic _xdrug effects
650	0	4	_aGenes, BRCA1 _xphysiology
650	0	4	_aGenes, p53 _xphysiology
650	0	4	_aMammary Neoplasms, Animal _xdrug therapy
650	0	4	_aMaximum Tolerated Dose
650	0	4	_aMice
650	0	4	_aMice, Knockout
650	0	4	_aPhthalazines _xpharmacology
650	0	4	_aPiperazines _xpharmacology
650	0	4	_aTopoisomerase I Inhibitors
650	0	4	_aTopotecan _xadministration & dosage
700	1		_aKersbergen, Ariena
700	1		_avan der Burg, Eline
700	1		_ade Water, Niels
700	1		_avan Tellingen, Olaf
700	1		_aGunnarsdottir, Sjöfn
700	1		_aJaspers, Janneke E
700	1		_aPajic, Marina
700	1		_aNygren, Anders O H
700	1		_aJonkers, Jos
700	1		_aBorst, Piet
700	1		_aRottenberg, Sven
773	0		_tCancer research _gvol. 70 _gno. 4 _gp. 1700-10
856	4	0	_uhttps://doi.org/10.1158/0008-5472.CAN-09-3367 _zAvailable from publisher's website
999			_c19516007 _d19516007